FLT3 INHIBITORS FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA: SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Santos, A. [1 ]
Pereira, C. [1 ]
Freitas, D. [2 ]
机构：
[1] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil
[2] Univ Jose do Rosario Vellano UNIFENAS BH, Belo Horizonte, MG, Brazil
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
MT1
引用
收藏
页码：S378 / S378
页数：1
相关论文
共 50 条
  • [31] Efficacy analysis of different FLT3 inhibitors in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndrome
    Swaminathan, Mahesh
    Aly, Mai M.
    Khan, Abdul Moiz
    Share, Bayan Al
    Dhillon, Vikram
    Lalo, Enxhi
    Ramos, Harry
    Akers, Katherine G.
    Kim, Seongho
    Balasubramanian, Suresh
    EJHAEM, 2023, 4 (01): : 165 - 173
  • [32] Safety of FLT3 inhibitors in patients with acute myeloid leukemia
    Cerchione, Claudio
    Peleteiro Raindo, Andres
    Mosquera Orgueira, Adrian
    Mosquera Torre, Alicia
    Bao Perez, Laura
    Marconi, Giovanni
    Isidori, Alessandro
    Perez Encinas, Manuel Mateo
    Martinelli, Giovanni
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (09) : 851 - 865
  • [33] Incorporating FLT3 inhibitors in the frontline treatment of FLT3 mutant acute myeloid leukemia
    Wang, Eunice S.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (02) : 154 - 162
  • [34] Efficacy and safety of second-generation FLT3 inhibitors in acute myeloid leukemia: A systematic review and meta-analysis of randomized controlled trials
    Lin, Wei-Ting
    Chao, Chien-Ming
    Lin, Cheng-Yao
    Hsu, Ya-Ting
    Hsiao, Sheng-Yen
    Weng, Teng-Song
    MOLECULAR AND CLINICAL ONCOLOGY, 2024, 21 (06)
  • [35] IS ETHNICITY AN EFFECT MODIFIER BETWEEN FLT3 INHIBITORS AND SALVAGE THERAPY FOR RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA?
    Santos, A.
    Pereira, C.
    Freitas, D.
    VALUE IN HEALTH, 2022, 25 (12) : S379 - S380
  • [36] FLT3 inhibitors as maintenance therapy post allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients with FLT3 mutations: A meta-analysis
    Fei, Xinhong
    Zhang, Shuqin
    Gu, Jiangying
    Wang, Jingbo
    CANCER MEDICINE, 2023, 12 (06): : 6877 - 6888
  • [37] Incorporating FLT3 inhibitors into acute myeloid leukemia treatment regimens
    Pratz, Keith
    Levis, Mark
    LEUKEMIA & LYMPHOMA, 2008, 49 (05) : 852 - 863
  • [38] Advancing treatment of acute myeloid leukemia: the future of FLT3 inhibitors
    Elshoury, Amro
    Przespolewski, Amanda
    Baron, Jeffrey
    Wang, Eunice S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (03) : 273 - 286
  • [39] Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia
    Short, Nicholas J.
    Kantarjian, Hagop
    Ravandi, Farhad
    Daver, Naval
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10
  • [40] FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia The Start of an Era?
    Pemmaraju, Naveen
    Kantarjian, Hagop
    Ravandi, Farhad
    Cortes, Jorge
    CANCER, 2011, 117 (15) : 3293 - 3304
12345